MARKET

BHC

BHC

Bausch Health Companies Inc
NYSE

Real-time Quotes | Nasdaq Last Sale

31.00
-0.89
-2.79%
After Hours: 30.72 -0.28 -0.90% 18:36 12/13 EST
OPEN
31.85
PREV CLOSE
31.89
HIGH
31.97
LOW
30.94
VOLUME
4.95M
TURNOVER
--
52 WEEK HIGH
31.97
52 WEEK LOW
17.20
MARKET CAP
10.93B
P/E (TTM)
-17.7112
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BHC and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 17 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

BHC News

  • Benzinga's Top Upgrades, Downgrades For December 13, 2019
  • Benzinga.1d ago
  • The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer
  • Benzinga.1d ago
  • The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer
  • Benzinga.1d ago
  • Top Ranked Value Stocks to Buy for December 13
  • Zacks.1d ago

More

Industry

Pharmaceuticals
-0.74%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Name
Price
%Change

About BHC

Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.
More

Webull offers Bausch Health Companies Inc (BHC) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.